Organon & Co
727 hedge funds and large institutions have $4.13B invested in Organon & Co in 2023 Q2 according to their latest regulatory filings, with 61 funds opening new positions, 224 increasing their positions, 292 reducing their positions, and 97 closing their positions.
83% more call options, than puts
Call options by funds: $27.7M | Put options by funds: $15.1M
0.06% more ownership
Funds ownership: 77.96% → 78.02% (+0.06%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
5% less funds holding
Funds holding: 767 → 727 (-40)
12% less capital invested
Capital invested by funds: $4.67B → $4.13B (-$539M)
23% less repeat investments, than reductions
Existing positions increased: 224 | Existing positions reduced: 292
37% less first-time investments, than exits
New positions opened: 61 | Existing positions closed: 97
Top Buyers
| 1 |
Goldman Sachs
New York
|
+$31.6M |
| 2 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$31.5M |
| 3 |
Invesco
Atlanta,
Georgia
|
+$27.4M |
| 4 |
Millennium Management
New York
|
+$16M |
| 5 |
JP Morgan Chase
New York
|
+$15.1M |
Top Sellers
| 1 |
AC
Armistice Capital
New York
|
-$75.3M |
| 2 |
Bank of New York Mellon
New York
|
-$53.3M |
| 3 |
Impax Asset Management Group
London,
United Kingdom
|
-$32.3M |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$30.2M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$16.9M |
OGN Hedge Fund Activity: Q2 2023 in Review
727 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Organon & Co (OGN) for Q2 2023, worth a combined $4.13B — down 12% from $4.67B a quarter earlier.
Sellers outnumbered buyers: 97 funds closed out of OGN and 61 opened new positions — a net loss of 36 holders — while 292 trimmed existing stakes and 224 added.
The largest buyer was Goldman Sachs, adding an estimated $31.6M. The largest seller was Armistice Capital, exiting entirely with an estimated $75.3M sold.
- 727 institutional investors held Organon & Co (OGN) as of Q2 2023, down from 767 in Q1 2023.
- Funds reported $4.13B of Organon & Co stock for Q2 2023, down 12% quarter-over-quarter.
- 61 funds opened new Organon & Co positions in Q2 2023 and 97 closed out, a net change of -36 holders.
- The largest Organon & Co buyer in Q2 2023 was Goldman Sachs, an estimated $31.6M added.
- The largest Organon & Co seller in Q2 2023 was Armistice Capital, an estimated $75.3M sold.
Based on aggregated 13F filings for Q2 2023.